Molecular Laboratory Articles & Analysis
16 news found
Molecular Health, an international biotech IT company based in Heidelberg, Germany, has received European Union certification for its MH Guide clinical decision support software (SaaS) under the new In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR). The MH Guide software, which is used in molecular pathology laboratories, is the first of its ...
MAHADEVAN, HARVARD UNIVERSITY, USA – BIOPHYSICS MARTA SHAHBAZI, PHD, MRC LABORATORY OF MOLECULAR BIOLOGY, CAMBRIDGE, UK – DEVELOPMENTAL BIOLOGY JUSTIN EYQUEM, PHD, UNIVERSITY OF CALIFORNIA SAN FRANCISCO, USA – GENE EDITING SHIN KAWAMATA, MD, PHD, R&D CENTER FOR CELL THERAPY, FBRI, KOBE, JAPAN – CELL THERAPY MANUFACTURING & ...
As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD) system from Thermo Fisher Scientific will enable them to expand their assay menus and IVD testing capabilities moving forward. ...
Our preliminary research with the HERO system has demonstrated that it was able to kill lung cancer cells in a laboratory setting, and we believe it has the potential to aid in the recovery of COVID-19 infected patients and lung cancer ...
Molecular Health has launched the latest version of its analysis software MH Guide. This software, which is used by pathology laboratories and molecular tumor boards, now has improved search capabilities to identify patient- relevant clinical studies. ...
About JCRI-ABTS JCRI-ABTS is a state-of-the-art BSL 2 translational molecular research laboratory focusing on Plasma Oncotherapeutics (a new cancer treatment modality) using Canady Helios™ Cold Plasma to investigate the potential of Cold Atmospheric Plasma to selectively treat ...
Recently accepted for publication in the International Journal of Molecular Sciences, the article “Canady Helios Cold Plasma Induces Breast Cancer Cell Death by Oxidation of Histone mRNA” described how research scientists at JCRI/ABTS treated four (4) breast cancer cell lines with Canady Helios Cold Plasma (CHCP) at different dosages and monitored the progress of ...
About JCRI-ABTS JCRI-ABTS is a state-of-the-art BSL 2 translational molecular research laboratory focusing on Plasma Oncotherapeutics (a new cancer treatment modality) using Canady Helios™ Cold Plasma to investigate the potential of Cold Atmospheric Plasma to selectively treat cancer. ...
The event will also feature a talk on liquid biopsy by Beatriz Bellosillo, Ph.D., Head of the Molecular Biology laboratory at Laboratori de Diagnòstic Molecular, Hospital Del Mar, Barcelona. ...
Now totaling nearly 60,000 square feet in laboratory, greenhouse and office space, the facilities support the company's commercial advancements, including ramping seed production and the deployment of additional JMax Knowledge Centers? ...
The microarrays include exon level measurements and the ability to interrogate lincRNAs, a new class of non-coding RNAs that have been implicated in a number of disease states, including cancer. The project will include two molecular profiling laboratories in Mexico, two in Brazil, and one each in Argentina, Chile and Uruguay. ...
"We would not have found this connection if we only worked with rat or mice cells," said Michael Resnick, Ph.D., principal investigator in the Laboratory of Molecular Genetics (LMG) and corresponding author on the paper. ...
"We would not have found this connection if we only worked with rat or mice cells," said Michael Resnick, Ph.D., principal investigator in the Laboratory of Molecular Genetics (LMG) and corresponding author on the paper. ...
In addition to the supply of HIV tests and DBS sample collection for research use, Abbott is collaborating with CHAI to develop a "turn-key" laboratory solution, including training protocols on instruments that will be used to establish fully functioning molecular diagnostic laboratories in regions where such facilities do not currently exist. ...
Wellems, M.D., Ph.D., chief of the laboratory of malaria and vector research at the National Institute of Allergy and Infectious Diseases; and Carl Wu, Ph.D., chief of the laboratory of biochemistry and molecular biology, Center for Cancer Research at the National Cancer Institute. ...
In addition, QIAGEN announced a partnership with Merck in 2009 focused on increasing access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world, the first time a vaccine manufacturer and a molecular diagnostics company are collaborating to address the burden of cervical cancer with a comprehensive approach. ...